Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-09-000755
Filing Date
2009-03-16
Accepted
2009-03-16 14:25:43
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w73200e10vk.htm 10-K 1563001
2 EXHIBIT 10.43 w73200exv10w43.htm EX-10.43 356177
3 EXHIBIT 10.44 w73200exv10w44.htm EX-10.44 102632
4 EXHIBIT 21 w73200exv21.htm EX-21 2155
5 EXHIBIT 23.1 w73200exv23w1.htm EX-23.1 1211
6 EXHIBIT 31.1 w73200exv31w1.htm EX-31.1 8098
7 EXHIBIT 31.2 w73200exv31w2.htm EX-31.2 8094
8 EXHIBIT 32.1 w73200exv32w1.htm EX-32.1 3025
9 EXHIBIT 32.2 w73200exv32w2.htm EX-32.2 3025
10 GRAPHIC w73200w7320003.gif GRAPHIC 7732
11 GRAPHIC w73200w7320001.gif GRAPHIC 715
12 GRAPHIC w73200w7320002.gif GRAPHIC 710
  Complete submission text file 0000950133-09-000755.txt   2061878
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33609 | Film No.: 09683702
SIC: 2834 Pharmaceutical Preparations